DD135488A5 - Verfahren zur herstellung von pyridazinon-derivaten - Google Patents

Verfahren zur herstellung von pyridazinon-derivaten

Info

Publication number
DD135488A5
DD135488A5 DD78205053A DD20505378A DD135488A5 DD 135488 A5 DD135488 A5 DD 135488A5 DD 78205053 A DD78205053 A DD 78205053A DD 20505378 A DD20505378 A DD 20505378A DD 135488 A5 DD135488 A5 DD 135488A5
Authority
DD
German Democratic Republic
Prior art keywords
pyridazinone derivatives
preparing
preparing pyridazinone
derivatives
pyridazinone
Prior art date
Application number
DD78205053A
Other languages
English (en)
Inventor
Germaine Thuillier
Sylviane S J Mignonac
Original Assignee
Rolland Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolland Sa A filed Critical Rolland Sa A
Publication of DD135488A5 publication Critical patent/DD135488A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • C07D237/16Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD78205053A 1977-04-28 1978-04-27 Verfahren zur herstellung von pyridazinon-derivaten DD135488A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7712888A FR2388799A1 (fr) 1977-04-28 1977-04-28 Derives de pyridazinone, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
DD135488A5 true DD135488A5 (de) 1979-05-09

Family

ID=9190051

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78205053A DD135488A5 (de) 1977-04-28 1978-04-27 Verfahren zur herstellung von pyridazinon-derivaten

Country Status (18)

Country Link
US (1) US4188388A (de)
JP (1) JPS53135993A (de)
AU (1) AU3552678A (de)
BE (1) BE866492A (de)
DD (1) DD135488A5 (de)
DE (1) DE2817649A1 (de)
ES (2) ES469234A1 (de)
FR (1) FR2388799A1 (de)
GB (1) GB1584119A (de)
IE (1) IE46730B1 (de)
IL (1) IL54547A0 (de)
IT (1) IT1111174B (de)
LU (1) LU79520A1 (de)
NL (1) NL7804374A (de)
NZ (1) NZ187085A (de)
PL (1) PL112610B1 (de)
PT (1) PT67958B (de)
ZA (1) ZA782209B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP1889198B1 (de) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US8076334B2 (en) * 2007-09-20 2011-12-13 Hoffmann-La Roche Inc. Prodrugs of thyroid hormone analogs
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (de) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermale freisetzungszusammensetzung mit wirkstoff-calciumphosphat-partikelkomplexen und anwendungsverfahren
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
PL227639B1 (pl) 2014-05-28 2018-01-31 Werner Kenkel Spólka Z Ograniczona Odpowiedzialnoscia Platforma ekspozycyjna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1913265A1 (de) * 1969-03-15 1970-10-01 Basf Ag Verfahren zur Herstellung von 2-Alkylpyridazoniumverbindungen

Also Published As

Publication number Publication date
IT1111174B (it) 1986-01-13
IL54547A0 (en) 1978-07-31
FR2388799A1 (fr) 1978-11-24
PL112610B1 (en) 1980-10-31
BE866492A (fr) 1978-10-27
DE2817649A1 (de) 1978-11-09
GB1584119A (en) 1981-02-04
IE780778L (en) 1978-10-28
US4188388A (en) 1980-02-12
JPS53135993A (en) 1978-11-28
NZ187085A (en) 1979-12-11
NL7804374A (nl) 1978-10-31
FR2388799B1 (de) 1980-06-27
AU3552678A (en) 1979-11-01
PT67958A (fr) 1978-05-01
IT7822754A0 (it) 1978-04-27
ES476449A1 (es) 1979-05-16
IE46730B1 (en) 1983-09-07
PL206456A1 (pl) 1979-04-23
LU79520A1 (fr) 1978-11-28
PT67958B (fr) 1979-11-14
ES469234A1 (es) 1980-05-16
ZA782209B (en) 1979-04-25

Similar Documents

Publication Publication Date Title
DD137107A5 (de) Verfahren zur herstellung von spiro-hydantoinderivaten
DD129006A5 (de) Verfahren zur herstellung von pyrimidinderivaten
AT362782B (de) Verfahren zur herstellung von 4-hydroxypyrrolidin-2-on-derivaten
DD135380A5 (de) Verfahren zur herstellung von 4-acylamino-phenyl-aethanolaminen
AT362781B (de) Verfahren zur herstellung von 4-hydroxypyrrolidin-2-on-derivaten
DD135500A5 (de) Verfahren zur herstellung von polyaetheramid-saeuren
DD138904A5 (de) Verfahren zur herstellung von prostanderivaten
DD139256A5 (de) Verfahren zur herstellung von substituierten diaminoanthrachinonen
DD135482A5 (de) Verfahren zur herstellung von p-benzochinon
DD138651A5 (de) Verfahren zur herstellung von alpha-fluormethyl-alpha-amino-alkansaeuren
DD135383A5 (de) Verfahren zur herstellung von 1-azolyl-3,3-dimethyl-1-phenoxy-butan-2-onen
DD137584A5 (de) Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten
DD135488A5 (de) Verfahren zur herstellung von pyridazinon-derivaten
DD134089A5 (de) Verfahren zur herstellung von 4-diphenylmethylen-1-hydroxybenzylpiperidinen
DD137926A5 (de) Verfahren zur herstellung von n-substituierten alpha-ketocarbonsaeureamiden
DD132790A5 (de) Verfahren zur herstellung von uracilderivaten
PT71741B (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
ATA55178A (de) Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten
DD138202A5 (de) Verfahren zur herstellung von veraetherten cycloalkanolen
AT363625B (de) Verfahren zur herstellung von 21-hydroxy-20methyl-pregnan-derivaten
AT366695B (de) Verfahren zur herstellung von 3-brommethyl-3cephemsulfoxydderivaten
DD134517A5 (de) Verfahren zur herstellung von p-nitroso-diphenylhydroxylaminen
DD134524A5 (de) Verfahren zur herstellung von 1-oxadethiacephamverbindungen
DD134429A3 (de) Verfahren zur herstellung von 1-(beta-d-ribofuranosyl)-5-fluorpyrimidin-2-on
DD135908A5 (de) Verfahren zur herstellung von halogenarylmalonamidooxacephalosporinen